The UK Government Health and Social Committee invited submissions to review the current policy positions in the UK. Read Drug Science’s written submission here, and watch the oral submissions given by several other leading UK drug policy and health organisations:
Health and harms:
- What is the extent of health harms resulting from drug use?
Prevention and early intervention:
- What are the reasons for both the initial and the continued, sustained use of drugs? This refers to the wide spectrum of use, from high-risk use to the normalisation of recreational use.
- How effective and evidence-based are strategies for prevention and early intervention in managing and countering the drivers of use? This includes whether a whole-system approach is taken.
Treatment and harm reduction:
- How effective and evidence-based is treatment provision? This refers to both healthcare services and wider agencies, and the extent to which joined-up care pathways operate.
- Is policy is sufficiently geared towards treatment? This includes the extent to which health is prioritised, in the context of the Government’s criminal justice-led approach.
- What would a high-quality, evidence-based response to drugs look like?
- What responses to drugs internationally stand out as particularly innovative and / or relevant, and what evidence is there of impact in these cases?